Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Monica Del Rey"'
Autor:
Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, Kelly Chien, Monica Del Rey, Sanam Loghavi, Guillermo Montalban-Bravo, Vera Adema, Bethany Wildeman, Rashmi Kanagal-Shamanna, Alexandre Bazinet, Helen T. Chifotides, Natthakan Thongon, Xavier Calvo, Jesús María Hernández-Rivas, Maria Díez-Campelo, Guillermo Garcia-Manero, Simona Colla
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-5 (2024)
Abstract The molecular mechanisms of venetoclax-based therapy failure in patients with acute myeloid leukemia were recently clarified, but the mechanisms by which patients with myelodysplastic syndromes (MDS) acquire secondary resistance to venetocla
Externí odkaz:
https://doaj.org/article/f8ae8a5e42764717965abbcac1ae14a5
Autor:
Jose Maria Bastida, Monica Del Rey, Nuria Revilla, Rocio Benito, Martin Perez-Andrés, Berta González, Susana Riesco, Kamila Janusz, Jose Padilla, Ana Hortal Benito-Sendin, David Bueno, Elena Blanco, Maria Hernández-Rivas, Vicente Vicente, Jose Rivera, Ramon González-Porras, Maria Luisa Lozano
Publikováno v:
Platelets, Vol 28, Iss 4, Pp 417-420 (2017)
Wiskott–Aldrich syndrome (WAS) is a rare X-linked recessive disease resulting from variants in the WAS gene, characterized by a triad of immunodeficiency, eczema, and thrombocytopenia. Despite the fact that WAS is traditionally differentiated from
Externí odkaz:
https://doaj.org/article/66527a6e834042db90566ef4c3032450
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mónica del Rey González, Sohini Chakraborty, Jesús María Hernández-Sánchez, María Diez Campelo, Christopher Y. Park, Jesús María Hernández Rivas
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Treatment with the hypomethylating agent 5-azacytidine (AZA) increases survival in high-risk (HR) myelodysplastic syndrome (MDS) patients, but predicting patient response and overall survival remains challenging. To address these issues, we analyzed
Externí odkaz:
https://doaj.org/article/c7fb6c7685b74917942b55da558c1fcc
Autor:
Prijatelj, Krešimir, Dodaj, Arta, Sesar, Kristina, Ojeda Pérez, Monica, del Rey Alamillo, Rosario, Howard, Dominika, Gerding Speno, Ashton
Qualitative research on sexting is not at all rare internationally (for an overview, see Doyle et al., 2021). Despite this steady increase in qualitative international research, qualitative studies examining the phenomenon of sexting in non-Western,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::d1b4314688ee6df40f93904f2f4a32d8
https://www.bib.irb.hr/1202653
https://www.bib.irb.hr/1202653
Publikováno v:
Blood. 134:106-107
In this issue of Blood, Hsu et al show that myelodysplastic syndrome (MDS) cells can be efficiently reprogrammed into induced pluripotent stem cells (iPSCs) to capture the clonal intermediates that appeared during MDS progression.1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sofía María Toribio Castelló, Sandra Castaño, Angela Villaverde-Ramiro, Esperanza Such, Montserrat Arnan, Francesc Solé, Marina Díaz Beyá, María Díez-Campelo, Mónica del Rey, Teresa González, Jesus Hernández Rivas
Publikováno v:
HemaSphere, Vol 7, p e877555b (2023)
Externí odkaz:
https://doaj.org/article/641fb7d44c22400caf72c8e0302030fa
Autor:
Miguel Quijada‐Álamo, Claudia Pérez‐Carretero, María Hernández‐Sánchez, Ana‐Eugenia Rodríguez‐Vicente, Ana‐Belén Herrero, Jesús‐María Hernández‐Sánchez, Marta Martín‐Izquierdo, Sandra Santos‐Mínguez, Mónica del Rey, Teresa González, Araceli Rubio‐Martínez, Alfonso García de Coca, Julio Dávila‐Valls, José‐Ángel Hernández‐Rivas, Helen Parker, Jonathan C. Strefford, Rocío Benito, José‐Luis Ordóñez, Jesús‐María Hernández‐Rivas
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 2, Pp n/a-n/a (2021)
Abstract Background Several genetic alterations have been identified as driver events in chronic lymphocytic leukemia (CLL) pathogenesis and oncogenic evolution. Concurrent driver alterations usually coexist within the same tumoral clone, but how the
Externí odkaz:
https://doaj.org/article/ee07f326975144ad8bd15cff85606abf